Jardiance 25 Mg
Price range: $350.00 through $570.00
| Quantity Value | Price | Price/Unit | Quantity | Add To Cart |
|---|---|---|---|---|
| 100 Tablet S | $350.00 | $3.50 / Piece |
|
|
| 200 Tablets | $570.00 | $2.85 / Piece |
|
SKU : N/A
Category : Other
Jardiance 25 mg
Jardiance 25 mg is a prescription medicine containing empagliflozin, which belongs to a class of medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors. It is primarily used in adults with certain forms of type 2 diabetes and is also used for specific heart failure and chronic kidney disease indications. Jardiance works mainly by helping the kidneys remove excess glucose from the body through the urine.
Empagliflozin may provide benefits beyond blood glucose control in appropriately selected patients, including reducing the risk of certain cardiovascular and kidney-related complications. The exact approved uses can vary according to the patient’s medical condition, age, and local prescribing guidelines.
Uses of Jardiance 25 mg
Jardiance 25 mg may be prescribed to help improve blood sugar control in adults with type 2 diabetes mellitus, together with an appropriate diet and physical activity program. It may be used alone or in combination with other diabetes medicines when additional blood glucose control is required.
Empagliflozin is also used in certain adults with heart failure to reduce the risk of cardiovascular death and hospitalization for heart failure. In appropriate patients, it can be beneficial even when diabetes is not present.
Another important indication is chronic kidney disease (CKD) in certain adults. Empagliflozin may help reduce the risk of worsening kidney disease and certain cardiovascular outcomes in eligible patients.
Jardiance is not intended to treat type 1 diabetes unless specifically directed under an appropriate specialist treatment plan. SGLT2 inhibitors can increase the risk of diabetic ketoacidosis, including in some situations where blood glucose is not extremely high.
How Jardiance Works
Empagliflozin works by inhibiting the SGLT2 protein in the kidneys. Normally, SGLT2 helps reabsorb glucose from urine back into the bloodstream. By blocking this protein, empagliflozin reduces glucose reabsorption and allows more glucose to be eliminated through urine.
This process can lower blood glucose levels and may also cause the body to lose some sodium and water. These effects are believed to contribute to some of the cardiovascular and kidney benefits observed with empagliflozin.
How to Take Jardiance 25 mg
Jardiance should be taken exactly as prescribed by a doctor. It is generally taken once daily, with or without food. The prescribed dose depends on the condition being treated and the individual’s medical circumstances.
Patients should swallow the tablet as directed and should not change the dose without consulting their healthcare professional. Adequate fluid intake is important unless a doctor has recommended fluid restriction because of a specific medical condition.
If a dose is missed, patients should follow the instructions provided by their doctor or pharmacist and should not take an extra dose to compensate.
Common Side Effects
Because Jardiance increases the amount of glucose passed in the urine, some people may experience increased urination. Other possible side effects include genital fungal infections, urinary tract infections, thirst, and symptoms related to dehydration.
Some patients may experience dizziness, particularly if blood pressure decreases due to fluid loss. The risk of low blood sugar is generally greater when Jardiance is combined with insulin or certain medicines such as sulfonylureas.
Patients should contact their healthcare professional if side effects are persistent, severe, or unusual.
Important Safety Information
One important but uncommon complication associated with SGLT2 inhibitors is diabetic ketoacidosis (DKA). Symptoms may include nausea, vomiting, abdominal pain, unusual tiredness, difficulty breathing, or confusion. DKA can sometimes occur even when blood glucose is not extremely high. Patients experiencing these symptoms should seek urgent medical attention.
Jardiance can also contribute to dehydration and low blood pressure, especially in people taking diuretics, older adults, or individuals with reduced fluid intake. Patients should follow their healthcare professional’s advice regarding fluids.
Rare but serious infections involving the genital or perineal area have also been reported. Severe pain, swelling, redness, fever, or feeling very unwell in this region requires urgent medical evaluation.
Kidney Function and Surgery
Kidney function should be assessed before and during treatment when appropriate because the suitability and effectiveness of empagliflozin depend partly on kidney function and the indication being treated.
Healthcare professionals may recommend temporarily stopping Jardiance before certain major surgeries or during serious acute illness because of the risk of ketoacidosis. Patients should follow specific instructions from their medical team rather than stopping treatment independently.
Drug Interactions
Jardiance can interact with other medicines, particularly insulin and insulin-releasing medicines, which may increase the risk of hypoglycemia. Diuretics may also increase the risk of dehydration or low blood pressure.
Patients should tell their doctor or pharmacist about all prescription medicines, over-the-counter medicines, vitamins, and supplements they use.
Storage
Jardiance should be stored according to the instructions on the product packaging and kept away from excessive heat and moisture. Keep the medicine out of the reach of children and do not use it after the expiry date.
Conclusion
Jardiance 25 mg contains empagliflozin, an SGLT2 inhibitor that helps the kidneys eliminate excess glucose through urine. It is used in appropriate adults with type 2 diabetes and is also prescribed for certain patients with heart failure and chronic kidney disease.
In addition to improving blood glucose control, empagliflozin may provide important cardiovascular and kidney benefits in eligible patients. However, it can cause increased urination, dehydration, genital infections, and, rarely, serious diabetic ketoacidosis.
Jardiance should therefore be used under the supervision of a qualified healthcare professional. Patients should follow the prescribed dose, maintain appropriate hydration, understand warning symptoms, and inform their healthcare team about other medicines and medical conditions. Regular follow-up may be necessary to monitor blood glucose, kidney function, blood pressure, and overall treatment response.
| Pack Size |
100 Tablet/s ,200 Tablets |
|---|
